Peptide-Coated PLGA Nanoparticles for Size Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional methods for forming peptide-coated nanoparticles, such as those using PLGA, often result in nanoparticle aggregation and precipitation, producing particles with diameters in the micrometer range rather than the desired nanosized, spherical, and uniform particles necessary for effective biological permeation.
Innovation Solution
A method involving sequential steps of diluting hexapeptides or tripeptides in nanopure water, adding PLGA solutions at controlled rates and temperatures, and dialyzing to produce nanoparticles with diameters of ≤100 nm, utilizing self-assembled peptide coatings like RGDFFF, NGRFFF, EKHFFF, or TPP-KFF, and binding cargo molecules like dyes or therapeutics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional nanoparticle formulation methods are used, then nanoparticles can be formed, but nanoparticle aggregation and precipitation occur resulting in micrometer-sized particles instead of nanosized particles
Solution Approach 1:
The peptide coating is applied to the nanoparticle surface before final formulation and storage. This preliminary coating action prevents aggregation and precipitation during subsequent handling and storage, ensuring nanoparticles remain nanosized rather than aggregating into micrometer-sized particles
Solution Approach 2:
The peptide layer acts as an intermediary substance between the nanoparticle core and the aqueous environment. This intermediary coating prevents direct interaction between nanoparticles that would cause aggregation, while also providing stability in biological environments
2Adaptability or versatility
If peptide coating is applied to nanoparticles, then biocompatibility and targeted delivery are improved, but conventional methods cause aggregation and precipitation
Solution Approach 1:
The patent optimizes multiple parameters including peptide concentration, coating time, temperature, and pH to achieve stable nanoparticle formation. By carefully controlling these parameters, the method achieves both nanosized uniform particles and effective peptide coating for biological permeation without aggregation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method effectively produces biocompatible, biodegradable, and stable nanoparticles with precise size and morphology, enhancing their suitability for medical applications, including targeted drug delivery and diagnostics.
Implementation Method 1
The coatings are self-assembled layers selected from RGDFFF (SEQ ID NO: 1); NGRFFF (SEQ ID NO: 2), EKHFFF (SEQ ID NO: 3) or TPP-KFF
Data Source
AI summary
A method for forming peptide-coated nanoparticles. The nanoparticles are polylactic co-glycol polymer (PLGA). The coatings are self-assembled layers selected from RGDFFF (SEQ ID NO: 1); NGRFFF (SEQ ID NO: 2), EKHFFF (SEQ ID NO: 3) or TPP-KFF. A cargo molecule, such as a dye or a therapeutic may be bound to the nanoparticle.